Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status

Alimentary Pharmacology & Therapeutics
P ZapaterM Pérez-Mateo

Abstract

To study the pharmacokinetic and metabolism profiles of a single dose of acetaminophen in patients with cirrhosis. Oral acetaminophen (1000 mg) was administered to seven healthy subjects and 14 patients with cirrhosis (nine Child-Pugh A or B and five Child-Pugh C grade), being five without and nine with oesophageal varices. Plasma levels of acetaminophen and its metabolites were determined by HPLC. Patients showed a higher mean area under the curve concentration-time (67.4 +/- 22.4 mg h/L vs. 38.8 +/- 4.3 mg h/L; P = 0.01), a lower clearance (166.7 +/- 85.0 mL/min vs. 367.8 +/- 62.5 mL/min; P = 0.01) and higher elimination half-life (3.8 +/- 1.1 h vs. 2.0 +/- 0.4 h; P = 0.01) of acetaminophen than healthy volunteers. The appearance in blood and the urinary excretion of metabolites in patients did not differ from healthy subjects. Absorption profile was faster in patients. Patients with lower mean and systolic arterial pressure had lower AUC of acetaminophen, independently of liver dysfunction stage. Patients with cirrhosis had a higher AUC and lower clearance of acetaminophen. Acetaminophen attained earlier therapeutic concentrations in patients with oesophageal varices. Mean and systolic arterial pressures were significantly a...Continue Reading

References

Oct 1, 1979·Archives of Internal Medicine·M MuggeoG Crepaldi
Jul 1, 1979·European Journal of Clinical Pharmacology·J A ForrestL F Prescott
May 28, 1977·British Medical Journal·J A ForrestL F Prescott
Nov 13, 1975·The New England Journal of Medicine·G Gross, C V Perrier
May 1, 1986·Clinical Pharmacokinetics·C Jorup-RönströmS Britton
Sep 1, 1983·Antimicrobial Agents and Chemotherapy·E A SwabbA Sugerman
Jan 1, 1983·Clinical Pharmacology and Therapeutics·G D Benson
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S MøllerJ H Hernriksen
Jan 1, 1995·Journal of Hepatology·H TakikawaM Yamanaka
Jan 1, 1996·European Journal of Clinical Pharmacology·S S al-ObaidyP S Collier
Jul 1, 1997·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J F Westphal, J M Brogard
Mar 7, 2002·British Journal of Anaesthesia·M E Stocker, J E Montgomery
Oct 3, 2003·Seminars in Liver Disease·William M Lee
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laura P JamesJack A Hinson

❮ Previous
Next ❯

Citations

Mar 10, 2010·Inflammopharmacology·Garry G GrahamAnthoulla Mohamudally
Jan 5, 2007·Biological & Pharmaceutical Bulletin·Shigeo ShinodaYoko Ohe
Dec 24, 2015·Expert Review of Clinical Pharmacology·M A PenaP Zapater
Feb 19, 2016·European Journal of Clinical Pharmacology·Naglaa M El-LakkanySanaa S Botros
Oct 16, 2015·British Journal of Clinical Pharmacology·Kelly L HaywardJennifer H Martin
Nov 25, 2005·Journal of Pharmaceutical Sciences·L KalantziDirk M Barends
Oct 9, 2013·Clinics in Liver Disease·Chalermrat Bunchorntavakul, K Rajender Reddy
Jun 28, 2006·Gastroentérologie Clinique Et Biologique·César YaghiRaymond Sayegh
Aug 2, 2008·Alimentary Pharmacology & Therapeutics·N K Gupta, J H Lewis
Feb 26, 2013·Journal of Clinical Pharmacology·Michael GanetskySteven D Salhanick
Aug 27, 2014·Basic & Clinical Pharmacology & Toxicology·Pedro ZapaterJose Such
Apr 14, 2015·Journal of Gastroenterology and Hepatology·Anders E JunkerTina Vilsbøll
Aug 5, 2017·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tomomi HosonoMasato Homma
Jun 18, 2019·Journal of Pain & Palliative Care Pharmacotherapy·Anne E Schweighardt, Katherine M Juba
May 19, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mayur K LadumorBhagwat Prasad
Nov 4, 2004·Alimentary Pharmacology & Therapeutics·R J Aspinall, P J Pockros
Jan 4, 2021·Regulatory Toxicology and Pharmacology : RTP·Hartmut JaeschkeGary Eichenbaum
Feb 27, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nikhil VojjalaVirendra Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
D R DouglasM J Smilkstein
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Anne M LarsonAcute Liver Failure Study Group
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Garry G GrahamRichard O Day
© 2022 Meta ULC. All rights reserved